Multitargeted therapies for multiple myeloma

Autophagy

Volumn 9, Issue 2, 2013, Pages 255-257

  Kharaziha, Pedram ^a   Ceder, Sophia ^a   Sanchez, Claire ^a   Panaretakis, Theocharis ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5T33MM; ABT737; Autophagy; Bone marrow stroma; Cell death; Multiple myeloma; Sorafenib; Tyrosine kinase inhibitor

Indexed keywords

3 METHYLADENINE; 4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; BECLIN 1; BH3 PROTEIN; BORTEZOMIB; CHLOROQUINE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN MCL 1; PROTEIN P62; PROTEIN TYROSINE KINASE INHIBITOR; RAPAMYCIN; SORAFENIB; SYNDECAN 1; TYROSINE KINASE RECEPTOR;

APOPTOSIS; AUTOPHAGY; BONE MARROW CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; DRUG CYTOTOXICITY; DRUG EFFICACY; FIBROBLAST; HUMAN; MONOTHERAPY; MULTIPLE MYELOMA; NONHUMAN; NOTE; OVERALL SURVIVAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR MICROENVIRONMENT;

EID: 84873673610     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.22738     Document Type: Note

References (0)